Trade margin on medical devices capped to end menace of exaggerated MRP, says Divisional Commissioner Kashmir

Published On 2022-04-04 10:04 GMT   |   Update On 2022-04-04 10:04 GMT

Srinagar: The Divisional Commissioner Kashmir, Pandurang K Pole on Sunday said that the administration has achieved a major breakthrough in keeping the menace of printing exaggerated Maximum Retail Price (MRP) by pharmaceutical-companies on the label of medical devices.A Maximum Retail Price is a maximum price that can be charged from the consumers in India. The development took place...

Login or Register to read the full article

Srinagar: The Divisional Commissioner Kashmir, Pandurang K Pole on Sunday said that the administration has achieved a major breakthrough in keeping the menace of printing exaggerated Maximum Retail Price (MRP) by pharmaceutical-companies on the label of medical devices.

A Maximum Retail Price is a maximum price that can be charged from the consumers in India. 

The development took place after Divisional Commissioner Kashmir, Pandurang K Pole took serious note of information that most of medical devices were found carrying trade margin of 100-800%.
Earlier, Divisional Commissioner Kashmir had taken up the matter of printing inflated MRP on medical devices with the National Pharmaceutical Pricing Authority (NPPA), Government of India. In response, the NPPA has acknowledged the loophole and has assured action in this regard.
The matter of unethical practice of printing inflated MRPs on medical devices by pharmaceutical companies was brought into the notice of Divisional Administration by Legal Metrology department.

Read also: NPPA fixes ceiling price of two coronary stents



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News